Table 2.
Oral drugs | |
5‐FU | (fluorouracil) |
Tegafur | |
UFT | (tegafur‐uracil) |
5’‐DFUR | (doxifluridine) |
HCFU | (carmofur) |
S‐1 | (tegafur‐gimeracil‐oteracil potassium) |
UFT+LV | (tegafur‐uracil+leucovorin) |
Cape | (capecitabine) |
regorafenib | |
TAS‐102 | (trifludine‐tipiracil hydrochloride) |
Injectable drugs | |
5‐FU | (fluorouracil) |
mitomycin C | |
IRI | (irinotecan) |
5‐FU+l‐LV | (fluorouracil+l‐leucovorin) |
OX | (oxaliplatin) |
Bmab | (bevacizumab) |
Rmab | (ramucirumab) |
Cmab | (cetuximab) |
Pmab | (panitumumab) |